Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.

Obici L, Berk JL, González-Duarte A, Coelho T, Gillmore J, Schmidt HH, Schilling M, Yamashita T, Labeyrie C, Brannagan TH 3rd, Ajroud-Driss S, Gorevic P, Kristen AV, Franklin J, Chen J, Sweetser MT, Wang JJ, Adams D.

Amyloid. 2020 Mar 4:1-10. doi: 10.1080/13506129.2020.1730790. [Epub ahead of print]

PMID:
32131641
2.

Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.

Kouton L, Boucraut J, Devaux J, Rajabally YA, Adams D, Antoine JC, Bourdain F, Brodovitch A, Camdessanché JP, Cauquil C, Ciron J, Dubard T, Echaniz-Laguna A, Grapperon AM, Juntas-Morales R, Kremer L, Kuntzer T, Labeyrie C, Lanfranco L, Léger JM, Maisonobe T, Mavroudakis N, Mecharles-Darrigol S, Merle P, Noury JB, Rouaud V, Tard C, Théaudin M, Vallat JM, Viala K, Attarian S, Delmont E.

Clin Neurophysiol. 2020 Apr;131(4):921-927. doi: 10.1016/j.clinph.2020.01.013. Epub 2020 Feb 6.

PMID:
32078921
3.

Small fiber neuropathy in Sjögren syndrome: Comparison with other small fiber neuropathies.

Descamps E, Henry J, Labeyrie C, Adams D, Ghaidaa AN, Vandendries C, Adam C, Aiello D, Mariette X, Seror R.

Muscle Nerve. 2020 Apr;61(4):515-520. doi: 10.1002/mus.26824. Epub 2020 Feb 15.

PMID:
32012291
4.

Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis.

Bunod R, Adams D, Cauquil C, Francou B, Labeyrie C, Bourenane H, Adam C, Algalarrondo V, Slama M, Darce-Bello M, Barreau E, Labetoulle M, Rousseau A.

Br J Ophthalmol. 2020 Jan 16. pii: bjophthalmol-2019-315381. doi: 10.1136/bjophthalmol-2019-315381. [Epub ahead of print]

PMID:
31949094
5.

[Cervical spinal sarcoidosis mimicking compressive cervical myelopathy: Poor prognosis after surgery].

Urbain F, Labeyrie C, Herbrecht A, Nasser G, Cauquil C, Adam C, Lambotte O, Goujard C, Adams D, Noel N.

Rev Med Interne. 2020 Feb;41(2):78-88. doi: 10.1016/j.revmed.2019.11.006. Epub 2019 Dec 10. French.

PMID:
31836247
6.

[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Puyade M, Labeyrie C, Badoglio M, Cintas P, Guenounou S, Lansiaux P, Marjanovic Z, Nicolas G, Pomies A, Terriou L, Torregrosa Diaz JM, Baron C, Castilla Llorente C, Yakoub-Agha I, Farge D.

Bull Cancer. 2020 Jan;107(1S):S104-S113. doi: 10.1016/j.bulcan.2019.11.002. Epub 2019 Dec 7. Review. French.

PMID:
31818426
7.

Comparison of Lewis-Sumner syndrome with chronic inflammatory demyelinating polyradiculoneuropathy patients in a tertiary care centre.

Fargeot G, Maisonobe T, Psimaras D, Debs R, Lenglet T, Adams D, Vandendries C, Labeyrie C, Viala K.

Eur J Neurol. 2020 Mar;27(3):522-528. doi: 10.1111/ene.14101. Epub 2019 Oct 24.

PMID:
31574194
8.

Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.

Vukusic S, Rollot F, Casey R, Pique J, Marignier R, Mathey G, Edan G, Brassat D, Ruet A, De Sèze J, Maillart E, Zéphir H, Labauge P, Derache N, Lebrun-Frenay C, Moreau T, Wiertlewski S, Berger E, Moisset X, Rico-Lamy A, Stankoff B, Bensa C, Thouvenot E, Heinzlef O, Al-Khedr A, Bourre B, Vaillant M, Cabre P, Montcuquet A, Wahab A, Camdessanché JP, Tourbah A, Guennoc AM, Hankiewicz K, Patry I, Nifle C, Maubeuge N, Labeyrie C, Vermersch P, Laplaud DA; OFSEP Investigators.

JAMA Neurol. 2019 Sep 3. doi: 10.1001/jamaneurol.2019.2670. [Epub ahead of print]

PMID:
31479149
9.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

10.

Diagnostic usefulness of plexus magnetic resonance imaging in chronic inflammatory demyelinating polyradiculopathy without electrodiagnostic criteria of demyelination.

Fargeot G, Viala K, Theaudin M, Labeyrie MA, Costa R, Léger JM, Adams D, Vandendries C, Labeyrie C.

Eur J Neurol. 2019 Apr;26(4):631-638. doi: 10.1111/ene.13868. Epub 2018 Dec 10.

PMID:
30431216
11.

Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas.

Théaudin M, Lozeron P, Algalarrondo V, Lacroix C, Cauquil C, Labeyrie C, Slama MS, Adam C, Guiochon-Mantel A, Adams D; French FAP Network (CORNAMYL) Study Group.

Eur J Neurol. 2019 Mar;26(3):497-e36. doi: 10.1111/ene.13845. Epub 2018 Dec 11.

PMID:
30350904
12.

Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy.

Collins M, Pellat A, Antoni G, Agostini H, Labeyrie C, Adams D, Carbonnel F.

PLoS One. 2018 Aug 30;13(8):e0201869. doi: 10.1371/journal.pone.0201869. eCollection 2018.

13.

18F-FDG PET/CT and MRI in Necrotizing Autoimmune Myopathy: "The Scarface Sign".

Pelissou C, Lerolle N, Labeyrie C, Durand E, Besson FL.

Clin Nucl Med. 2018 Feb;43(2):147-149. doi: 10.1097/RLU.0000000000001955.

PMID:
29261630
14.

[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Pugnet G, Castilla-Llorente C, Puyade M, Terriou L, Badoglio M, Deligny C, Guillaume-Jugnot P, Labeyrie C, Benzidia I, Faivre H, Lansiaux P, Marjanovic Z, Bourhis JH, Faucher C, Furst S, Huynh A, Martin T, Vermersch P, Yakoub-Agha I, Farge D.

Bull Cancer. 2017 Dec;104(12S):S169-S180. doi: 10.1016/j.bulcan.2017.06.019. Epub 2017 Nov 22. Review. French.

PMID:
29173974
15.

Familial amyloid polyneuropathy.

Adams D, Cauquil C, Labeyrie C.

Curr Opin Neurol. 2017 Oct;30(5):481-489. doi: 10.1097/WCO.0000000000000476. Review.

PMID:
28678039
16.

Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy.

Dekeyser M, de Goër de Herve MG, Hendel-Chavez H, Labeyrie C, Adams D, Nasser GA, Gasnault J, Durrbach A, Taoufik Y.

Open Forum Infect Dis. 2017 May 16;4(2):ofx100. doi: 10.1093/ofid/ofx100. eCollection 2017 Spring.

17.

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Dyck PJ, Kincaid JC, Dyck PJB, Chaudhry V, Goyal NA, Alves C, Salhi H, Wiesman JF, Labeyrie C, Robinson-Papp J, Cardoso M, Laura M, Ruzhansky K, Cortese A, Brannagan TH 3rd, Khoury J, Khella S, Waddington-Cruz M, Ferreira J, Wang AK, Pinto MV, Ayache SS, Benson MD, Berk JL, Coelho T, Polydefkis M, Gorevic P, Adams DH, Plante-Bordeneuve V, Whelan C, Merlini G, Heitner S, Drachman BM, Conceição I, Klein CJ, Gertz MA, Ackermann EJ, Hughes SG, Mauermann ML, Bergemann R, Lodermeier KA, Davies JL, Carter RE, Litchy WJ.

Muscle Nerve. 2017 Nov;56(5):901-911. doi: 10.1002/mus.25563. Epub 2017 Apr 7.

18.

Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?

Adams D, Beaudonnet G, Adam C, Lacroix C, Théaudin M, Cauquil C, Labeyrie C.

Rev Neurol (Paris). 2016 Oct;172(10):645-652. doi: 10.1016/j.neurol.2016.08.007. Epub 2016 Sep 21. Review.

PMID:
27663057
19.

Transcriptome Analysis of Peripheral Blood in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients Identifies TNFR1 and TLR Pathways in the IVIg Response.

Richard A, Corvol JC, Debs R, Reach P, Tahiri K, Carpentier W, Gueguen J, Guillemot V, Labeyrie C, Adams D, Viala K, Cohen Aubart F.

Medicine (Baltimore). 2016 May;95(19):e3370. doi: 10.1097/MD.0000000000003370.

20.

Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.

Labeyrie C, Cauquil C, Sarov M, Adams D, Denier C.

Muscle Nerve. 2016 Jun;54(1):166-7. doi: 10.1002/mus.25076. Epub 2016 May 27. No abstract available.

PMID:
26873805
21.

TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies.

Adams D, Cauquil C, Labeyrie C, Beaudonnet G, Algalarrondo V, Théaudin M.

Expert Opin Pharmacother. 2016;17(6):791-802. doi: 10.1517/14656566.2016.1145664. Epub 2016 Mar 10. Review.

PMID:
26800456
22.

Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, "EdAmyl".

Théaudin M, Cauquil C, Antonini T, Algalarrondo V, Labeyrie C, Aycaguer S, Clément M, Kubezyk M, Nonnez G, Morier A, Bourges C, Darras A, Mouzat L, Adams D.

Amyloid. 2014 Dec;21(4):225-30. doi: 10.3109/13506129.2014.941463. Epub 2014 Jul 29.

PMID:
25069833

Supplemental Content

Loading ...
Support Center